| Literature DB >> 35248489 |
Kartik Bhamidipati1, Kevin Wei2.
Abstract
Rheumatoid arthritis is an autoimmune disease that causes significant morbidity. Application of cellular profiling techniques such as single-cell transcriptomics and spatial transcriptomics has uncovered novel pathogenic cell types in RA joint tissues and revealed marked heterogeneity in the cellular composition among RA patients. Together, these insights provide exciting opportunities to translate discoveries into precision medicine in RA. The present review aims to highlight novel insights into RA pathology and discuss key steps needed to translate these discoveries into actionable changes in clinical practice. We review the efforts to identify surrogate biomarkers that could be used to predict RA synovial tissue phenotypes and the corresponding responses to therapy. Finally, we discuss the opportunity to develop novel patient-derived organoid systems as a platform for therapeutic target validation.Entities:
Keywords: Organoids; Precision medicine; Rheumatoid arthritis; Single-cell RNAseq; Spatial transcriptomics
Mesh:
Substances:
Year: 2022 PMID: 35248489 PMCID: PMC8977251 DOI: 10.1016/j.berh.2022.101742
Source DB: PubMed Journal: Best Pract Res Clin Rheumatol ISSN: 1521-6942 Impact factor: 4.098